95 related articles for article (PubMed ID: 19148132)
1. Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D.
Metzner A; Precht C; Fehse B; Fiedler W; Stocking C; Günther A; Mayr GW; Jücker M
Gene Ther; 2009 Apr; 16(4):570-3. PubMed ID: 19148132
[TBL] [Abstract][Full Text] [Related]
2. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
[TBL] [Abstract][Full Text] [Related]
3. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.
Metzner A; Horstmann MA; Fehse B; Ortmeyer G; Niemeyer CM; Stocking C; Mayr GW; Jücker M
Gene Ther; 2007 Apr; 14(8):699-703. PubMed ID: 17268534
[TBL] [Abstract][Full Text] [Related]
5. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.
Täger M; Horn S; Latuske E; Ehm P; Schaks M; Nalaskowski M; Fehse B; Fiedler W; Stocking C; Wellbrock J; Jücker M
Gene Ther; 2017 Nov; 24(11):749-753. PubMed ID: 29143813
[TBL] [Abstract][Full Text] [Related]
6. Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.
Nalaskowski MM; Ehm P; Rehbach C; Nelson N; Täger M; Modest K; Jücker M
Cell Signal; 2018 Sep; 49():87-94. PubMed ID: 29852247
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
[TBL] [Abstract][Full Text] [Related]
8. The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nuclei.
Nalaskowski MM; Metzner A; Brehm MA; Labiadh S; Brauer H; Grabinski N; Mayr GW; Jücker M
Cell Signal; 2012 Mar; 24(3):621-8. PubMed ID: 21864674
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of SHIP gene in acute leukemia.
Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ohno R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):420-6. PubMed ID: 15363123
[TBL] [Abstract][Full Text] [Related]
10. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
11. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
[TBL] [Abstract][Full Text] [Related]
12. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
13. [Mutation analysis of SHIP gene in acute leukemia].
Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ryuzo O
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):385-8. PubMed ID: 15355687
[TBL] [Abstract][Full Text] [Related]
14. A novel ABL1 fusion to the SH2 containing inositol phosphatase-1 (SHIP1) in acute lymphoblastic leukemia (ALL).
Kakadia PM; Tizazu B; Mellert G; Harbott J; Röttgers S; Quentmeier H; Spiekermann K; Bohlander SK
Leukemia; 2011 Oct; 25(10):1645-9. PubMed ID: 21625237
[No Abstract] [Full Text] [Related]
15.
Olufunmilayo EO; Holsinger RMD
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895194
[TBL] [Abstract][Full Text] [Related]
16. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
Rogers SY; Bradbury D; Kozlowski R; Russell NH
Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
[TBL] [Abstract][Full Text] [Related]
17. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27.
Zhou P; Kitaura H; Teitelbaum SL; Krystal G; Ross FP; Takeshita S
J Immunol; 2006 Dec; 177(12):8777-84. PubMed ID: 17142780
[TBL] [Abstract][Full Text] [Related]
18. The role of SHIP1 in T-lymphocyte life and death.
Gloire G; Erneux C; Piette J
Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
[TBL] [Abstract][Full Text] [Related]
19. Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection.
Hadidi S; Antignano F; Hughes MR; Wang SK; Snyder K; Sammis GM; Kerr WG; McNagny KM; Zaph C
Mucosal Immunol; 2012 Sep; 5(5):535-43. PubMed ID: 22535180
[TBL] [Abstract][Full Text] [Related]
20. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.
Luo JM; Yoshida H; Komura S; Ohishi N; Pan L; Shigeno K; Hanamura I; Miura K; Iida S; Ueda R; Naoe T; Akao Y; Ohno R; Ohnishi K
Leukemia; 2003 Jan; 17(1):1-8. PubMed ID: 12529653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
